Home  |  Careers  |  Contact Us  |  Sitemap
About
Getz Pharma
  Research &
Development
  Business
Partnerships
  Marketing &
Sales
  Technical
Operations
  Products   Getz Pharma Cares

Back

Prasugrel

Country:  

Therapeutic Segment

Platelet Aggregation Inhibitor

Generic Name

Prasugrel

Indication

Prisa (Prasugrel) is indicated to reduce the rate of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with percutaneous coronary intervention as follows:

  • Patients with unstable angina or non-ST-elevation myocardial infarction.
  • Patients with ST-elevation myocardial infarction when managed with primary or delayed percutaneous coronary intervention.


Brands

Prisa

Form

Tablets

(Hover on images to enlarge)

Home :  Legal
©2014 Getz Pharma (Pvt) Ltd.

Site Powered by USFI